Overview

Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to identify genetic, brain morphologic, and environmental biomarkers that contribute to the pathophysiology of attention-deficit/hyperactivity disorder (ADHD).
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Childrens Hospital
Treatments:
Atomoxetine Hydrochloride
Methylphenidate